High-Quality Plasmid DNA Manufacturing Strategies for Advanced Therapeutic Products
As viral vectors are drawing attention in the use of advanced therapeutics, the demand in high-quality plasmid DNA production is also becoming greater. Not limited to the production of viral vectors, plasmid DNA can be served either as a delivery vehicle itself, or a template for mRNA vaccines. For different applications, the requirements for the plasmid DNA production are different. ProBio has accumulated experience in plasmid production for lentiviral vectors, AAV vectors, mRNA vaccines, and DNA vaccines. We will share our cases in dealing with these challenges in plasmid production.
In this webinar, we will cover
The plasmid’s definition for different applications.
Optimization of plasmid manufacturing process.
Plasmid manufacturing for cell therapy products & mRNA vaccines.
Webinar Details
- Date: April 22nd, 2021
- Time: 15:00 CET / 21:00 SGT
- Speaker: Dr. Ming Ni, Technical manager, Plasmid Virus R&D Department
Speaker-related Webinars
High-Quality Plasmid DNA Manufacturing Strategies for Gene and Cell Therapeutics
In this webinar, Dr. Ming Ni, the CMC Project Manager for ProBio will provide a high-level overview of his experience in dealing with the challenges of plasmid production.
High-Quality Plasmid DNA Manufacturing Strategies for Gene and Cell Therapeutics
Success in gene and cell therapy has increased the demand for high-quality plasmid DNA production.
